Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dagmar Wirth

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
JHEP Reports : Innovation in Hepatology|April 17, 2025
Adapted hepatitis C virus clone infects innate immunity-deficient mouse hepatocytes with minimal human HCV entry factorsJulie Ann Sheldon, Melina Winkler, Qinggong Yuan, et al.
Plos One|December 17, 2011
Streamlining homogeneous glycoprotein production for biophysical and structural applications by targeted cell line developmentSonja Wilke, Lothar Groebe, Vitali Maffenbeier, et al.
The Journal of Clinical Investigation|December 12, 2024
Senescence of endothelial cells increases susceptibility to Kaposi's sarcoma-associated herpesvirus infection via CD109-mediated viral entryMyung-Ju Lee, Jun-Hee Yeon, Jisu Lee, et al.
Pathogens (Basel, Switzerland)|December 23, 2022
Type I Interferon Signaling Controls Gammaherpesvirus Latency In VivoJohannes Schwerk, Lucas Kemper, Kendra A Bussey, et al.
Plos Genetics|August 25, 2016
p120 Catenin-Mediated Stabilization of E-Cadherin Is Essential for Primitive Endoderm SpecificationTim Pieters, Steven Goossens, Lieven Haenebalcke, et al.
Plos Pathogens|March 4, 2014
Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latencyFranziska Dağ, Lars Dölken, Julia Holzki, et al.
Molecular Therapy. Nucleic Acids|September 16, 2024
Endothelial derived, secreted long non-coding RNAs <i>Gadlor1</i> and <i>Gadlor2</i> aggravate cardiac remodelingMerve Keles, Steve Grein, Natali Froese, et al.
Nature|November 15, 2019
Author Correction: Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
Nature|September 13, 2019
Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
Nature Communications|March 10, 2018
Expansion of functional personalized cells with specific transgene combinationsChristoph Lipps, Franziska Klein, Tom Wahlicht, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
JHEP Reports : Innovation in Hepatology|April 17, 2025
Adapted hepatitis C virus clone infects innate immunity-deficient mouse hepatocytes with minimal human HCV entry factorsJulie Ann Sheldon, Melina Winkler, Qinggong Yuan, et al.
Plos One|December 17, 2011
Streamlining homogeneous glycoprotein production for biophysical and structural applications by targeted cell line developmentSonja Wilke, Lothar Groebe, Vitali Maffenbeier, et al.
The Journal of Clinical Investigation|December 12, 2024
Senescence of endothelial cells increases susceptibility to Kaposi's sarcoma-associated herpesvirus infection via CD109-mediated viral entryMyung-Ju Lee, Jun-Hee Yeon, Jisu Lee, et al.
Pathogens (Basel, Switzerland)|December 23, 2022
Type I Interferon Signaling Controls Gammaherpesvirus Latency In VivoJohannes Schwerk, Lucas Kemper, Kendra A Bussey, et al.
Plos Genetics|August 25, 2016
p120 Catenin-Mediated Stabilization of E-Cadherin Is Essential for Primitive Endoderm SpecificationTim Pieters, Steven Goossens, Lieven Haenebalcke, et al.
Plos Pathogens|March 4, 2014
Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latencyFranziska Dağ, Lars Dölken, Julia Holzki, et al.
Molecular Therapy. Nucleic Acids|September 16, 2024
Endothelial derived, secreted long non-coding RNAs <i>Gadlor1</i> and <i>Gadlor2</i> aggravate cardiac remodelingMerve Keles, Steve Grein, Natali Froese, et al.
Nature|November 15, 2019
Author Correction: Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
Nature|September 13, 2019
Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
Nature Communications|March 10, 2018
Expansion of functional personalized cells with specific transgene combinationsChristoph Lipps, Franziska Klein, Tom Wahlicht, et al.
Pageof 10